ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
University of Wisconsin, Madison
University of Wisconsin, Madison
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Melanoma Institute Australia
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
University of Washington
M.D. Anderson Cancer Center
University of Southern California
Mayo Clinic